The influence of long-term awareness of hyperlipidemia and of 3 years of dietary counseling on depression, anxiety, and quality of life

Journal of Psychosomatic Research

Volumn 68, Issue 6, 2010, Pages 567-572

  Einvik, Gunnar ^a,b   Ekeberg, Oivind ^b,c   Lavik, Jorgen Glatved ^b   Ellingsen, Ingrid ^c   Klemsdal, Tor Ole ^c   Hjerkinn, Elsa M ^c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anxiety; Depression; Diet; Quality of life

Indexed keywords

CHOLESTEROL; OMEGA 3 FATTY ACID;

ADULT; ANXIETY DISORDER; ARTICLE; AWARENESS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEPRESSION; DIETARY INTAKE; HEALTH BEHAVIOR; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COUNSELING; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SOCIAL PSYCHOLOGY;

ADULT; ANXIETY DISORDERS; ATHEROSCLEROSIS; ATTITUDE TO HEALTH; AWARENESS; DEPRESSIVE DISORDER; DIET, FAT-RESTRICTED; DIET, REDUCING; FATTY ACIDS, OMEGA-3; FOLLOW-UP STUDIES; FOOD HABITS; HUMANS; HYPERCHOLESTEROLEMIA; LIFE STYLE; MALE; MASS SCREENING; MIDDLE AGED; NORWAY; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PERSONALITY INVENTORY; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SMOKING CESSATION;

EID: 77952950559     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2009.11.004     Document Type: Article

References (20)

1. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl 2):S1-S113.
2. Shaw C, Abrams K, Marteau TM Psychological impact of predicting individuals' risks of illness: a systematic review. Soc Sci Med 1999, 49:1571-1598.
3. Rudd P, Price MG, Graham LE. Consequence of worksite hypertension screening. Differential changes in psychosocial function. Am J Med 1986, 80:853-860.
4. Christensen B, Engberg M, Lauritzen T No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. Eur J Cardiovasc Prev Rehabil 2004, 11:239-243.
5. Fischer PM, Guinan KH, Burke JJ, Karp WB, Richards J Impact of a public cholesterol screening program. Arch Intern Med 1990, 150:2567-2572.
6. Brunner EJ, Rees K, Ward K, Burke M, Thorogood M Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev 2007, 4:CD002128.
7. Eriksson KM, Westborg CJ, Eliasson MC A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors. Scand J Public Health 2006, 34:453-461.
8. Koertge J, Weidner G, Elliott-Eller M, Scherwitz L, Merritt-Worden TA, Marlin R, et al. Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project. Am J Cardiol 2003, 91:1316-1322.
9. Michalsen A, Grossman P, Lehmann N, Knoblauch NT, Paul A, Moebus S, et al. Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: results of a randomized trial. Psychother Psychosom 2005, 74:344-352.
10. Vizza J, Neatrour DM, Felton PM, Ellsworth DL Improvement in psychosocial functioning during an intensive cardiovascular lifestyle modification program. J Cardiopulm Rehab and Prev 2007, 27:376-383.
11. Daubenmier JJ, Weidner G, Sumner MD, Mendell N, Merritt-Worden T, Studley J, et al. The contribution of changes in diet, exercise, and stress management to changes in coronary risk in women and men in the multisite cardiac lifestyle intervention program. Ann Behav Med 2007, 33:57-68.
12. Hjermann I, Velve BK, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981, 318:1303-1310.
13. Andersen LF, Solvoll K, Johansson LR, Salminen I, Aro A, Drevon CA Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol 1999, 150:75-87.
14. Zigmond AS, Snaith RP The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983, 67:361-370.
15. Herrmann C International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res 1997, 42:17-41.
16. Bjelland I. Anxiety and depression in the general population: issues related to assessment, comorbidity, and risk factors 2004, Section for Epidemiology and Medical Statistics, Department for Public Health and Primary Health Care, University of Bergen, Bergen.
17. Campbell A, Converse PE, Rogers WL The quality of American life 1976, Russell Sage Foundation, New York.
18. Hjerkinn EM, Seljeflot I, Ellingsen I, Berstad P, Hjermann I, Sandvik L, et al. Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr 2005, 81:583-589.
19. Bach Nielsen KD, Dyhr L, Lauritzen T, Malterud K. Long-term impact of elevated cardiovascular risk detected by screening. A qualitative interview study. Scand J Prim Health Care 2005, 23:233-238.
20. Ellingsen I, Hjermann I, Abdelnoor M, Hjerkinn EM, Tonstad S Dietary and antismoking advice and ischemic heart disease mortality in men with normal or high fasting triacylglycerol concentrations: a 23-y follow-up study. Am J Clin Nutr 2003, 78:935-940.